1.Microbial Contaminations of Ultrasonic Scalers, High-Speed Handpieces and Water Syringe Lines.
Beom Seok CHANG ; Jung Yun LEE ; Soo Boo HAN
The Journal of the Korean Academy of Periodontology 1997;27(4):941-947
The purpose of this study was to evaluate various methods of decontamination of ultrasonic scalers, high-speed handpieces and air-water syringes in dental equipments. Eimination of possible sources of microbial infection in dental operatories should be of primary importance. Microbial contamination levels of high speed handpieces, air-water syringes and ultrasonic scalers of 11 dental units in Seoul National University Hospital were evaluated after flushing the lines, alcohol sponge rubbing, or soaking in 0.1% chlorhexidine for 1,3 and 5 minutes. The result suggests that flushing the lines or soaking the tips in 0.1% chlorhexidine before use of the water systems may reduce the microbial levels. Soaking in 0.1% chlorhexidine for 5 minutes was most effective in reducing bacterial contamination.
Chlorhexidine
;
Decontamination
;
Dental Equipment
;
Flushing
;
Porifera
;
Seoul
;
Syringes*
;
Ultrasonics*
2.Usefulness of Modified Intravenous Analgesia: Initial Experience in Uterine Artery Embolization for Leiomyomata.
Seung Boo YANG ; Young Jin JUNG ; Dong Erk GOO ; Yun Woo JANG
Journal of the Korean Radiological Society 2006;54(4):259-264
PURPOSE: We wanted to evaluate the usefulness of modified intravenous analgesia for the management of pain during uterine artery embolization for leiomyomata. MATERIALS AND METHODS: Between April 2004 and July 2004, 15 patients with symptomatic fibroids underwent uterine artery embolization and pain management. Except the three patients for whom the Visual Analogue Scale (VAS) score was not obtained, twelve patients were included in this study. For pain management, epidural PCA (Patient Controlled Analgesia) was used in two patients, intravenous PCA was used in two patients and modified intravenous analgesia injection was used in eight patients. For all the patients, we used the 2.8 Fr coaxial microcatheter and 500-710 μm PVA particles for the embolic materials. The protocol of the modified intravenous analgesia injection was as follow, 1) prior to femoral artery puncture, 30 mg of ketorolac tromethamine (Tarasyn) was injected via an intravenous route. 2) At the time that the one side uterine artery embolization was finished, normal saline mixed 150 mg meperidine (Demerol) was administered through the side port of the intravenous line that was used for hydration. 3) Additional ketorolac tromethamine 30 mg was injected after 6 hour. The VAS score and side effects were then checked. After 12 hours, the VAS score was rechecked. If the VAS score was above 4, this was considered as failure of pain management. The VAS scores, complications and side effects for the modified intravenous analgesia injection were compared with that of IV PCA and epidural PCA. RESULTS: The average VAS score of the modified intravenous analgesia injection, intravenous PCA and epidural PCA was 1.4, 1 and 0, respectively; the number of additional intramuscular injections of analgesia was 0.5, 0.5 and 0, respectively. All the patients who underwent epidural PCA had back pain at the puncture site and 1 patient who underwent modified intravenous analgesia injection experienced mild dyspnea, but they easily recovered with such conservative treatment as an oxygen supply. No serious side effects or complications developed from the modified intravenous analgesia injection. CONCLUSION: Modified intravenous analgesia injection is well tolerated for the pain management of uterine fibroid embolization and it is a relatively inexpensive, safe method as used in our radiologic practice.
Analgesia*
;
Back Pain
;
Dyspnea
;
Femoral Artery
;
Humans
;
Injections, Intramuscular
;
Injections, Intravenous
;
Ketorolac Tromethamine
;
Leiomyoma
;
Meperidine
;
Oxygen
;
Pain Management
;
Passive Cutaneous Anaphylaxis
;
Punctures
;
Uterine Artery Embolization*
;
Uterine Artery*
;
Uterine Neoplasms
3.The Role of Prophylactic Gastrojejunostomy in Unresectable Periampullary Cancer.
Chung Yun KIM ; Won Jin LEE ; Yun Jung BOO ; Jin KIM ; Gyeong Chul LEE ; Tae Jin SONG ; Min Young CHO ; Sung Ock SUH ; Cheong Wung WHANG ; Young Chul KIM
Korean Journal of Hepato-Biliary-Pancreatic Surgery 2004;8(4):249-253
PURPOSE: It was reported that 25% to 75% patients with a periampullary cancer were found to be unresectable after exploratory surgery. The aim of this study was to evaluate the role of a prophylactic gastrojejunostomy in patients with an unresectable periampullary cancer. METHODS: During January 1999 to April 2004, a prophylactic gastrojejunostomy (GJ group) or no gastrojejunostomy (non-GJ group) was carried out for an unresectable periampullary cancer without a gastric outlet obstruction in 42 patients. The clinicopathological characteristics, postoperative complications and time survival were evaluated retrospectively. RESULTS: Of the 42 patients, a prophylactic gastrojejunostomy was performed in 24 cases. There were no immediate postoperative deaths in both groups, and the postoperative morbidity rate was similar in both groups (GJ group 10% vs non-GJ group 7%). There were no differences in the mean postoperative hospital stay (GJ group 29.5 days vs non-GJ group 26.8 days) and mean survival (GJ group 7.5 months vs non-GJ group 8.1 months) between the two groups. In the 5 of the non-GJ group (27%), a postoperative gastric outlet obstruction had developed. The median interval time between the initial exploration and the postoperative gastrojejunostomy was 4.1 months. CONCLUSION: Although a small number of patients developed a postoperative gastric outlet obstruction in the non-GJ group, the prophylactic gastrojejunostomy did not increase the number of postoperative complications or the length of hospitalstay. However, several patients who did not received the prophylactic gastrojejunostomy developed a duodenal obstruction. Furthermore they needed a prophylactic gastrojejunostomy. These results suggest that a prophylactic gastrojejunostomy is a necessary and feasible procedure for patients with an unresectable periampullary cancer without duodenal obstructive symptoms.
Bile Ducts
;
Duodenal Obstruction
;
Gastric Bypass*
;
Gastric Outlet Obstruction
;
Humans
;
Length of Stay
;
Pancreas
;
Postoperative Complications
;
Retrospective Studies
4.A Case of Adipsic Hypernatremia Associated with Anomalous Corpus Callosum in Adult with Mental Retardation.
Boo Gyoung KIM ; Ka Young KIM ; Youn Jeong PARK ; Keun Suk YANG ; Ji Hee KIM ; Hee Chan JUNG ; Hee Chul NAM ; Young Ok KIM ; Yu Seon YUN
Endocrinology and Metabolism 2012;27(3):232-236
Adipsic hypernatremia cause chronic hyperosmolality and hypernatremia through a combination of impaired thirst and osmotically stimulated antidiuretic hormone secretion. This syndrome can be grouped together as disorders of osmoreceptor dysfunction due to the various degrees of osmoreceptor destruction related with different types of intracranial lesions around the anterior hypothalamus, consistent with the location of primary osmoreceptor cells. Adipsic hypernatremia, associated with developmental disorder of corpus callosum, is very rare. Most cases are diagnosed at infancy and early childhood; the replacement of desmopressin is necessary. Herein, we report adipsic hypernatremia associated with anomalous corpus callosum in adult with mental retardation; they were treated with only free water without desmopressin.
Adult
;
Corpus Callosum
;
Deamino Arginine Vasopressin
;
Humans
;
Hypernatremia
;
Hypothalamus, Anterior
;
Intellectual Disability
;
Thirst
;
Water
5.A prevalence study of otitis media and related diseases in Korea in 1991.
Chong Sun KIM ; Ha Won JUNG ; Sung Hwa HONG ; Boo Hyun NAM ; Seung Ha OH ; Ic Tae KIM ; Won Ho CHUNG ; Young Suk YUN ; Chae Seo RHEE ; Jong Woo CHUNG ; Myung Koo KANG ; Keun Ho CHANG
Korean Journal of Otolaryngology - Head and Neck Surgery 1993;36(3):459-465
No abstract available.
Cross-Sectional Studies*
;
Korea*
;
Otitis Media*
;
Otitis*
;
Prevalence*
6.The clinical usefulness of non-invasive prenatal testing in pregnancies with abnormal ultrasound findings.
Hyeyeon BOO ; So Yun KIM ; Eui Sun SEOUNG ; Min Hyung KIM ; Moon Young KIM ; Hyun Mee RYU ; You Jung HAN ; Jin Hoon CHUNG
Journal of Genetic Medicine 2018;15(2):79-86
PURPOSE: This study aimed to evaluate the clinical usefulness of non-invasive prenatal testing (NIPT) as an alternative testing of invasive diagnostic testing in pregnancies with ultrasound abnormalities. MATERIALS AND METHODS: This was a retrospective study of pregnant women with abnormal ultrasound findings before 24 weeks of gestation between April 2016 and March 2017. Abnormal ultrasound findings included isolated increased nuchal translucency, structural anomalies, and soft markers. The NIPT or diagnostic test was conducted and NIPT detected trisomy 21 (T21), T18, T13 and sex chromosomal abnormalities. We analyzed the false positive and residual risks of NIPT based on the ultrasound findings. RESULTS: During the study period, 824 pregnant women had abnormal ultrasound findings. Among the study population, 139 patients (16.9%) underwent NIPT. When NIPT was solely performed in the patients with abnormal ultrasound findings, overall false positive risk was 2.2% and this study found residual risks of NIPT. However, the discordant results of NIPT differed according to the type of abnormal ultrasound findings. Discordant results were significant in the group with structural anomalies with 4.4% false positive rate. However, no discordant results were found in the group with single soft markers. CONCLUSION: This study found different efficacy of NIPT according to the ultrasound findings. The results emphasize the importance of individualized counseling for prenatal screening or diagnostic test based on the type of abnormal ultrasound.
Chromosome Aberrations
;
Congenital Abnormalities
;
Counseling
;
Diagnostic Tests, Routine
;
Down Syndrome
;
Female
;
Humans
;
Nuchal Translucency Measurement
;
Pregnancy*
;
Pregnant Women
;
Prenatal Diagnosis
;
Retrospective Studies
;
Ultrasonography*
7.A Case of Hemolytic Uremic Syndrome in a Lung Cancer Patient Treated with Gemcitabine.
Youn Jung PARK ; Keun Suk YANG ; Hong Soon JUNG ; Hee Chul NAM ; Seung Hye JUNG ; Boo Gyoung KIM ; Ka Young KIM ; Jung Ho KIM ; Young Ok KIM ; Yu Seon YUN
Tuberculosis and Respiratory Diseases 2012;72(2):207-211
Hemolytic uremic syndrome (HUS) is a rare disorder characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. HUS arises from a wide spectrum of conditions, and chemotherapeutic agents have been reported to be associated with HUS, including Mitomycin, Cisplatin, Bleomycin, and Gemcitabine. A 76-year-old man treated with Gemcitabine due to non-small cell lung cancer developed clinical and laboratory findings compatible with HUS. Gemcitabine was ceased and hemodialysis and plasma exchange were utilized and he recovered. A high level of suspicion for HUS is necessary when cancer patients are treated with Gemcitabine, and prompt recognition and treatment are also essential.
Acute Kidney Injury
;
Aged
;
Anemia, Hemolytic
;
Bleomycin
;
Carcinoma, Non-Small-Cell Lung
;
Cisplatin
;
Deoxycytidine
;
Hemolytic-Uremic Syndrome
;
Humans
;
Lung
;
Lung Neoplasms
;
Mitomycin
;
Plasma Exchange
;
Renal Dialysis
;
Thrombocytopenia
8.Corrigendum: Diffusion-Weighted Magnetic Resonance Imaging for Breast Cancer Screening in High-Risk Women: Design and Imaging Protocol of a Prospective Multicenter Study in Korea
Hee Jung SHIN ; Su Hyun LEE ; Vivian Youngjean PARK ; Jung Hyun YOON ; Bong Joo KANG ; Bo La YUN ; Tae Hee KIM ; Eun Sook KO ; Boo-Kyung HAN ; A Jung CHU ; Seo Young PARK ; Hak Hee KIM ; Woo Kyung MOON
Journal of Breast Cancer 2022;25(2):145-146
9.Diffusion-Weighted Magnetic Resonance Imaging for Breast Cancer Screening in High-Risk Women: Design and Imaging Protocol of a Prospective Multicenter Study in Korea
Hee Jung SHIN ; Su Hyun LEE ; Vivian Youngjean PARK ; Jung Hyun YOON ; Bong Joo KANG ; Bo La YUN ; Tae Hee KIM ; Eun Sook KO ; Boo-Kyung HAN ; A Jung CHU ; Seo Young PARK ; Hak Hee KIM ; Woo Kyung MOON
Journal of Breast Cancer 2021;24(2):218-228
Purpose:
Interest in unenhanced magnetic resonance imaging (MRI) screening for breast cancer is growing due to concerns about gadolinium deposition in the brain and the high cost of contrast-enhanced MRI. The purpose of this report is to describe the protocol of the Diffusion-Weighted Magnetic Resonance Imaging Screening Trial (DWIST), which is a prospective, multicenter, intraindividual comparative cohort study designed to compare the performance of mammography, ultrasonography, dynamic contrast-enhanced (DCE) MRI, and diffusion-weighted (DW) MRI screening in women at high risk of developing breast cancer.
Methods
A total of 890 women with BRCA mutation or family history of breast cancer and lifetime risk ≥ 20% are enrolled. The participants undergo 2 annual breast screenings with digital mammography, ultrasonography, DCE MRI, and DW MRI at 3.0 T. Images are independently interpreted by trained radiologists. The reference standard is a combination of pathology and 12-month follow-up. Each image modality and their combination will be compared in terms of sensitivity, specificity, accuracy, positive predictive value, rate of invasive cancer detection, abnormal interpretation rate, and characteristics of detected cancers. The first participant was enrolled in April 2019. At the time of manuscript submission, 5 academic medical centers in South Korea are actively enrolling eligible women and a total of 235 women have undergone the first round of screening. Completion of enrollment is expected in 2022 and the results of the study are expected to be published in 2026.Discussion: DWIST is the first prospective multicenter study to compare the performance of DW MRI and conventional imaging modalities for breast cancer screening in high-risk women. DWIST is currently in the patient enrollment phase.
10.Diffusion-Weighted Magnetic Resonance Imaging for Breast Cancer Screening in High-Risk Women: Design and Imaging Protocol of a Prospective Multicenter Study in Korea
Hee Jung SHIN ; Su Hyun LEE ; Vivian Youngjean PARK ; Jung Hyun YOON ; Bong Joo KANG ; Bo La YUN ; Tae Hee KIM ; Eun Sook KO ; Boo-Kyung HAN ; A Jung CHU ; Seo Young PARK ; Hak Hee KIM ; Woo Kyung MOON
Journal of Breast Cancer 2021;24(2):218-228
Purpose:
Interest in unenhanced magnetic resonance imaging (MRI) screening for breast cancer is growing due to concerns about gadolinium deposition in the brain and the high cost of contrast-enhanced MRI. The purpose of this report is to describe the protocol of the Diffusion-Weighted Magnetic Resonance Imaging Screening Trial (DWIST), which is a prospective, multicenter, intraindividual comparative cohort study designed to compare the performance of mammography, ultrasonography, dynamic contrast-enhanced (DCE) MRI, and diffusion-weighted (DW) MRI screening in women at high risk of developing breast cancer.
Methods
A total of 890 women with BRCA mutation or family history of breast cancer and lifetime risk ≥ 20% are enrolled. The participants undergo 2 annual breast screenings with digital mammography, ultrasonography, DCE MRI, and DW MRI at 3.0 T. Images are independently interpreted by trained radiologists. The reference standard is a combination of pathology and 12-month follow-up. Each image modality and their combination will be compared in terms of sensitivity, specificity, accuracy, positive predictive value, rate of invasive cancer detection, abnormal interpretation rate, and characteristics of detected cancers. The first participant was enrolled in April 2019. At the time of manuscript submission, 5 academic medical centers in South Korea are actively enrolling eligible women and a total of 235 women have undergone the first round of screening. Completion of enrollment is expected in 2022 and the results of the study are expected to be published in 2026.Discussion: DWIST is the first prospective multicenter study to compare the performance of DW MRI and conventional imaging modalities for breast cancer screening in high-risk women. DWIST is currently in the patient enrollment phase.